Ligatech Bioscience

Ligatech Bioscience

Ligatech Bioscience is an intrusive consumables developer.

HQ location
China
Launch date
Employees
Enterprise value
$110—165m
  • Edit
Get premium to view all results
DateInvestorsAmountRound
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
*

CNY200m

Series D
Total Funding000k
Notes (0)
More about Ligatech Bioscience
Made with AI
Edit

Established in 2014, Ligatech Bioscience is a Shanghai-based company specializing in the medical device sector with a focus on sports medicine. The firm is engaged in the research, development, manufacturing, and sale of products designed to address various joint injuries, positioning itself as a key domestic player in a market experiencing annual growth of over 20%. Ligatech provides a comprehensive range of solutions covering diagnosis, treatment, and exercise management, serving a client base that includes over 2,000 hospitals for its consumables and installations of small equipment in more than 200 hospitals.

The company's business model revolves around providing a full suite of products for sports-related medical procedures. Ligatech's product portfolio is extensive, featuring artificial ligaments, cruciate ligament fixation systems, meniscal repair systems, PEEK and metal wire anchors, high-strength non-absorbable medical sutures, and surgical traction frames. A significant achievement for the company was receiving the first domestic NMPA approval for an artificial ligament in China, a milestone that addressed a gap in the national market. Their offerings also include advanced diagnostic tools like a proprietary Digital Biplane X-ray Imaging System and active devices such as arthroscopy, shaver, and plasma surgical systems. The company holds over 160 patents and has obtained CE, ISO 13485, and NMPA certifications for its products.

Ligatech has demonstrated consistent growth and a strong ability to secure capital. Since its inception, the company has successfully completed multiple funding rounds, including a Series D financing in September 2023 that raised hundreds of millions of yuan, led by investors like XindaKunpeng and Legend Capital. This followed previous rounds, such as a CNY 314.8 million financing in April 2021. These financial infusions support the company's research and development efforts, which are carried out in collaboration with key sports medicine experts and universities, and its plans for overseas market expansion.

Keywords: sports medicine, medical devices, orthopedic implants, arthroscopy, artificial ligament, surgical consumables, ligament fixation, meniscal repair, suture anchors, biomedical materials, minimally invasive surgery, surgical equipment, orthopedic surgery, joint injury, medical technology, Digital Biplane X-ray, plasma surgical system, shaver system, cruciate ligament, rotator cuff repair

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo